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CHAPTER 1 
INTRODUCTION 
All trans-vitamin A alcohol or all trans-retinol (1), of molecular 
weight 286,46 Da, is an essential lipid soluble nutrient (2,3). 
Vitamin A was first discovered in eggs, milk, butter and fish liver 
. 
oils (2-5), and in plants (leafy green vegetables, carrots, yellow or 
orange coloured fruits) in the form of the provitamin, ~-carotene 
(1,3-7). The primary source of vitamin A is carotenoids, synthesised 
in plants and enzymatically converted to vitamin A in mammals (3,8). 
Vitamin A requirements are expressed in International Units (IU), and 
1,0 IU of vitamin A is supplied by (1,5,7): 
0,30 ~g of all trans-vitamin A alcohol 
0,344 ~g of all trans-vitamin A acetate 
0,55 ~g of all trans-vitamin A palmitate 
1,80 ~g (in humans) (5) or 0,6 ~g (in rats) (1,5) of all trans-~­
carotene (based on the assumption that only one-third of dietary ~­
carotene is available for human use and only one-half of "usable" 
carotene is converted to vitamin A (5).) 
Naturally occurring oxidation products of vitamin A alcohol are all 
trans-retinal (vitamin A aldehyde) and all trans-retinoic acid 
(vitamin A acid) (3,5). These three compounds have a common 
structure, (indicated in figure 1), wh ich includes a cyclic end group 
(the trimethyl cyclohexenyl ring), a dimethyl -substituted all trans-
tetraene chain and a polar hydroxyl, aldehyde or carboxyl end group 
(3,9,10). 
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FIGURE 1. 
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-CH20H = retinol 
-CHO = retinal 
-COOH = retinoic acid 
Basic structure of retinoids and nomenclature of three 
natural vitamin A compounds (3). 
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FIGURE 2. Structure of ~-carotene (C30), the precursor of vitamin A 
( 1 ) . 
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Each of the three regions of the retinoid molecule can be chemically 
modified in a number of ways, resulting in an unlimited number of 
chemical analogues, known as retinoids (3,10-13). These synthetic 
analogues may share all or some of the biological activities of the 
naturally occurring vitamin A compounds (8,9,11). The analogues may 
be less toxic, yet more potent to biological systems than the natural 
compounds (9,10,12-16) while others have no vitamin A activity 
indicating certain specific structural requirements for activity 
(3,8,9). 
Dietary vitamin A may be ingested in the form of long chain fatty acyl 
esters of retinol or as the provitamin ~-carotene (3,8,11,17) (figure 
2). The retinyl esters are hydrolysed to free retinol by pancreatic 
or brush border esterases before be i ng absorbed by the i ntest i na 1 
mucosa 1 epithe 1 i urn (1,3,5,6,8,11,18). ~-carotene, however, is 
absorbed and then enzymat i ca lly cleaved to yie 1 d two mo lecu 1 es of 
retinal, which are converted to retinol (1-3,11,17-19). Once inside 
the intestinal epithelial cell, the retinol is esterified with long 
chain fatty acids, primarily palmitate (1,3,5,8,11,18-20)' to form 
retinyl esters which then pass into the lymphatic system, are 
transported as chylomicrons in the blood and are taken up by the liver 
for storage (1,3,8,11,18,20). 
Mobil isation of the vitamin A from the 1 iver stores requires 
hydrolysis of the retinyl esters and the conjugation of the free 
retinol with a retinol binding protein (zinc-dependent (21-24)) which 
is produced by the liver (21,25-29). This conjugate is then released 
into the blood where it binds to the protein transthyretin 
3 
(8,18,29,30) (prealbumin) to form a ternary complex (25,27-29) which 
transports retinol to target organs and cells as required. Normal 
nourished animals maintain a relatively constant plasma level of 30 -
60 ~g/dl (2,11,22-24,31-35) (1 - 2 ~M) retinol, by an unknown 
mechanism of regulation . 
The a 1 coho 1 group of ret i no 1 can be revers i b ly ox i d i sed to ret i na 1 
(33,36 , 37) by retinol dehydrogenase (18), and further oxidised 
(irreversibly) to retinoic acid (3,5,18), depending on the type of 
vitamin A compound required. Retinoic acid, however, may only replace 
the requirement for either retinol or retinal in certain specific 
functions (3,14,18). 
Once inside the cell, retinol and retinoic acid can participate in a 
variety of metabol ic reactions. These depend on the cell type. Some 
of these reactions occur in many cell types while others occur only in 
specific cells with retinol and retinoic acid associated with specific 
enzymes or proteins (3). 
Both retinol and retinoic acid can be converted to glucuronides by the 
act ion of g 1 ucuronyl transferase, in the presence of UDP-g 1 ucuron i c 
ac i d. The g 1 ucuron i des are po 1 ar and water so 1 ub 1 e, and form the 
majority of excreted metabolites of vitamin A compounds (1-3,17,18). 
Retinol and retinoic acid form a complex with their respective 
cellular binding proteins (two distinct proteins, one specifically for 
each vitamin A compound (1,3,8,11,38,39) and differing from plasma 
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RBP (1,8,11,26,40)). The complex may then be translocated into the 
nucleus in the case of cellular retinoic acid binding protein 
(3,11,41), where the retinoic acid then binds to the chromatin (1,42), 
whereas cellular retinol binding protein may bind to . the nucleus 
(11,42,43) and release the retinol for binding to specific binding 
sites on the chromatin (1,3,26,43-45). Modification or regulation of 
gene expression may result from this binding. In other words, the 
potent i a 1 exi sts to act ivate or suppress the express i on of genes by 
the interact i on of vitami n A with the nuc leus (10,26,41 -43). and of 
particular interest is the interaction of vitamin A with the nucleus 
in neoplastic tissue. 
Initial experimental approaches in the study of vitamin A metabolism 
were primarily concerned with experimental animals fed vitamin A 
deficient or excess diets. In 1925, Wolbach and Howe (cited in 14) 
reported that the columnar epithelium of many tissues was replaced by 
rapidly multiplying squamous keratinising epithelial cells in vitamin 
A-deficient rats . The restoration of a normal vitamin A-containing 
diet fully reversed these effects. In 1926, Fujimaki (cited in 46) 
found that rats on a vitamin A-deficient diet had a higher incidence 
of spontaneous gastric carcinomas. This work could not be repeated in 
succeeding years, due to the difficulty in working with spontaneous 
tumours that occur at very low frequency . This led to the consequent 
introduct ion of chemi ca 1 carc i nogens to produce tumours wi th a high 
frequency in experimental animals, thus enabling a relationship 
between vitamin A and cancer to be more clearly shown. 
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It appeared that vitamin A metabolism may be altered in tumours, as 
very little or no vitamin A was found in malignant tissue when 
compared to tissue of origin . The amount of retinol present also 
depended on the type of tumour and chemical carcinogen used for the 
induction of the tumour (11). 
Contradictory results were obtained by early researchers when trying 
to relate different vitamin A levels (both deficiency and excess) to 
the incidence of various experimental tumours. More recently, there 
has been considerable evidence on the influence of various retinoids 
on the development of different epithel ial tumours both in man and 
experimental animals. 
In Table 1, experimental evidence indicating a relationship between 
vitamin A and cancer i s summari sed. The protect ive effects of the 
various retinoids against a number of epithelial tumours induced by a 
variety of carcinogens is emphasised by the data. A vitamin A 
deficiency, by comparison, results in increased growth of carcinogen-
induced tumours. A number of stud i es have reported no substant i a 1 
effect of retinoid supplementation and in some cases, adverse effects 
have been found (Table 1 and Table 2). This may be related to the 
dose of the carcinogen or of the retinoid, the type of retinoid, the 
dose schedule or the mode of administration of the retinoid. The 
reports may also indicate that certain types of tumour are refractory 
to the particular retinoid or to retinoids in general (13). 
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r ABL E I . The effect of 
epltne l ldl tumours lnduced 
carc Inoqens. 
dIfferent retlnolds on the growth o f 
In experImental anImals by a variety of 
SITE CARCIHOGEN RETINOID EFFECT REFERENCE 
Ski n 
lunq 
Mammary 
9 1 and 
Bladder 
Stomach 
Co Ion 
CervIx 
L her 
mouse 
mouse 
rabb1t 
mouse 
"t 
mouse 
hamster 
cot 
cat 
ra t 
mouse 
cat 
cat 
hamster 
hamster 
"t 
hamster 
hamster 
cot 
cot 
ADVERSE OR 1!.Q. EFFECTS 
Colon 
La rg e 
bowel 
Cheek 
pouch 
,,' 
,,' 
hams ter 
OMBA 
OMBA t TPA 
OHBA 
OHBA + 
croton oIl 
OMBA 
OHBA 
BP 
3HC 
3HC 
OHBA 
HNU 
BP 
MH U 
HO - 8BH 
BBH 
FANFT 
FANFT 
OHBA 
BP 
spontaneous 
OMH 
aflatoxIn 
OHBA 
BP 
OHAB 
aflatoxin 
MHU, OMH 
OMH 
OHBA 
R t ana 1 
RA -+ anal 
RA 
RA anal t 
aromat Ie Ret 
R pI! 1m 
low vH A 
R acet -+ anal 
R pa 1m -t 
R ac et 
vlt A det 
R acet ... Ret 
R acet ... anal 
R ac et 
RA anal 
RA anal 
vlt A ... anal 
RA 
vlt A def 
R pa 1 m 
R pa 1111 
vlt A def 
RA 
vlt A det 
R pa 1 m 
palm 
RA + anal 
vlt A det 
vlt A anal 
v1t A anal 
R acet ... 
R palm 
cltC!d In 11 
47 
cHed In II 
cIted In 15 
cIted In 11 
4B 
cited In 
cIted In 15 
cited In 49 
cIted In 13 
cIted I n 49 
cIted In 11 
cited In 15 
cited In 49 
cited In 13 
cited In 11 
cited In 4 
cHed In 2 
cited In 46 
cHed In 46 
cHed In 49 
cited In 50 
cited In 
cited In 15 
4B 
cIted In 49 
cIted In 11 
cited In 4 
cited In 2 
t .. Increased growth, ~ .. decreased growth, H .. no growth, R" 
retInol, RA .. retlnolc acid, Ret retinoid, R acet .. retlnyl acetate, 
R palm" retl ny l palmHate, anal .. analo!lue, def .. defIcient. 
DHBA .. dlmethylbenZllnthracene 
TPA .. 12-0-tetrlldecllnoylphorbol-13-acetate 
BP .. benzo(a)pyrene 
3MC 3-methylcholanthrene 
HNU .. N-methYl-nltrosourea 
BBN .. butyl-{4-hydroxy-butyl)n1trosamlne 
FANFT - H-(4~(5-nltro-2-furyl)-2-thjazolyl]formamlde 
OHH • 1,2-dlmethylhydrazlne 
OHAB - 3 ' -met hyl-4 -dlmethylaml noazobenzene 
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TABLE 2. The prophylaxis and therapy of hUman eplthellal cancers 
by some ret1nolds . 
-~ . . -------------- --- ----- .. --.----- ------------------ ----------------
SITE RETINOID INTAKE EFFECT REFERENCE 
Lu ng 1 nc r vlt A c lte d I n 52 
low v lt A c 1ted I n 51 
Bladder 1ncr vlt A c lted In 53 
1 nc r RA c lted In 10 
low v It A c lted In 
Stomach hcr vlt A c lted 1 n 4 
low vlt A 54 
Cerv 1x 1 nc r vlt A c lted 1 n 51 
low vlt A c lted In 11 
larynx lncr vlt A c1ted In 52 
l ncr RA C lted 1 n 10 
low vlt A cited 1 n 7 
Pros tate lncr vlt A c lted In 7 
low vlt A c 1ted In 9 
Prostat e lncr vlt A clted 1n 52 
t - Increas ed growth, 1· decreased growth, RA· retlnolc acid 
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Table 2 summarises the effects of retinoids on the prophylaxis and 
therapy of some human epithelial cancers. A low dietary vitamin A 
intake appears to result in increased tumour growth, while an 
increased dietary vitamin A intake or retinoic acid supplementation 
resu lts ina decreased tumour growth. These natura 1 ret i noi ds, 
however, are limited in their usefulness as chemopreventative agents 
both in man and experimental animal due to inadequate tissue 
distribution or excessive toxicity (9,12,13,15,15). Deposition of 
excessive amounts of retinol and retinyl esters occurs in the liver, 
without a dose-response relationship in blood levels. Thus for 
chemoprevention of cancer, it is essential that research into 
synthetic modification of the retinoid molecule progresses, in order 
to overcome the limiting processes of the natural retinoids. 
Significant advances in the study of vitamin A and cancer have 
occurred over the last few decades with the introduction of in vitro 
techniques. Initially, organ culture (prostate, trachea, mammary) was 
developed as an experimental tool, but this had a significant 
1 imitation in that mixed-cell populations were used, and thus 
replicate homogeneous samples were almost impossible to obtain. The 
introduction of cell culture methodology for the study of retinoid 
mechanism of action was a significant advancement, allowing molecular 
investigation into the role of retinoids in differentiation and 
carcinogenesis. 
Continuous cell 1 ines of both neoplastic and non-neoplastic (un-
transformed) origin have been widely used and retinoids have been 
shown to suppress chemical carcinogenesis and control both cell 
9 
proliferation and cell differentiation in various cell culture 
systems. A more detai led discussion of the effects of retinoids on 
various cell lines is presented in chapter 2. 
The a im of th i s study was to invest i gate the effect of v itami n A on 
the proliferation of untransformed and tumour cell lines cultured in 
our laboratory. In order to elucidate a possible site of action of 
vitamin A, ultrastructural examination of the cells was undertaken and 
in addition, the effect of vitamin A on a cell surface glycoprotein 
, 
fibronectin was examined, since vitamin A is known to affect the 
structure and development of cell membranes. 
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CHAPTER 2 
EFFECT OF VITAMIN A ON IN VITRO CELL PROLIFERATION 
INTRODUCTION 
The use of in vitro assay systems has, to a large extent, alleviated 
some of the problems associated with the study of retinoids in in vivo 
experimental systems. Such problems include the achievement of 
adequate tissue distribution, toxicity and the problem of 
distinguishing between specific and non-specific effects of retinoids 
(3,9). The external milieu in in vitro cell culture can be carefully 
controlled and hence effects due to specific additives in this 
environment can be determined with little non-specific interference. 
In recent years, a number of different cell lines, both untransformed 
and malignant, have been employed in the study of the effects of 
various vitamin A compounds. 
Lotan and Nicolson (55) undertook a study of the inhibition of 
proliferation of thirty-one different cell lines by retinoic acid and 
retinyl acetate, both at a concentration of IO-5M. The cells 
(untransformed as well as chemically, virally and spontaneously 
transformed) included lymphoma, myeloma, sarcoma, neuroblastoma and 
carcinoma lines from a variety of species (rat, mouse, hamster and 
human). Retinoic acid was found to be more effective than retinyl 
11 
acetate in the growth inhibition of many of the cell lines, the degree 
of i nh i bit i on varyi ng cons i derab ly from one ce 11 1 i ne to another. 
Direct cytotoxicity was excluded as a means of inhibiting cell growth. 
In another study, Lotan, Giotta, Nork and Nicolson (56) characterised 
the inhibitory effects of retinoic acid and retinyl acetate on the 
growth of two muri ne me 1 anoma ce 11 1 ines. They found that the 
inhibitory effects were dependent upon retinoid concentration 
(cytotoxicity excluded) and that both cell lines were more sensitive 
to retinoic acid than retinyl acetate, although one cell line was more 
sensitive than the other to both retinoids. The inhibitory effect of 
retinoid treatment could be reversed by replacing the retinoid-medium 
with control medium and the growth rate of the cells returned to that 
of the control cultures within 24 to 48 hours. 
The inhibitory nature of these retinoids on murine melanomas (56) and 
rat mammary adenocarcinomas (55) prompted Lotan (57) to test the 
ability of retinoic acid to inhibit the growth of cell lines derived 
from human melanomas and breast carcinomas . Only two of six melanoma 
1 i nes and two of four breast carc i noma 1 i nes (from human ma 1 i gnant 
tumours) showed inhibition due to retinoic acid addition. One non-
malignant breast tissue cell line was not affected by retinoic acid 
while the other exhibited a slight (13%) inhibition . These results 
demonstrated a diverse response to retinoic acid amongst cell lines 
derived from tumours of simi lar histopathological type. Lotan 
suggested that each tumour may respond differently to retinoic acid 
therapy, and this could limit the use of such treatment to those 
tumours which are found to be sensitive to retinoic acid in vitro. 
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Oion, Blalock and Gifford (5B) investigated the effect of retinoic 
ac i d on the growth of a transformed mouse L-ce 11 1 i ne in vitro and 
found that the inhibition which resulted suggested the restoration of 
contact inhibition. Retinoic acid-treated L-cells ceased 
proliferation at cell densities which corresponded to those of 
confluent monolayers, while control cells continued proliferation to 
reach densities two to four times higher. Medium depletion was not a 
factor in the cessation of proliferation in the treated cultures as 
replenishment of medium failed to stimulate further proliferation. 
Control cells, however, continued proliferating exponentially on 
medium replenishment . 
Patt, Itaya and Hakomori (59) reported that culturing hamster 
fibroblasts (NIL cells) and mouse fibroblasts (BALB/c 3T3 cells) in 
vitami n A-conta in i ng med i urn, enhanced contact ori entat ion and ce 11-
density dependent inhibition of cell growth. They also observed 
changes in the levels of a cell surface glycolipid and in LETS protein 
(large external transformation-sensitive protein, later called 
fibronectin - discussed in more detail in chapter 4). 
Jetten, Jetten, Shapiro and Poon (60) characterised the action of 
retinoic acid on the mouse fibroblast cell lines MB4-7 and BALB/c 3T6 
and 3T3, and the v irus transformed deri vat i ve of 3T3 ce 11 s, 3T3SV. 
They showed that the retinoid addition inhibited growth, caused 
morphological changes and increased cell-to-substratum adhesiveness in 
the 3T6, 3T3 and MB4-7 ce 11 s, but that the 3T3SV ce 11 s rema i ned 
unaffected. Their results also indicated an increase in LETS 
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glycoprotein (fibronectin) at the surface of the affected cells after 
retinoic acid treatment, which correlated well with the suggested role 
of this glycoprotein in increased adhesiveness. Treatment of the 3T6 
and 3T3 cells with retinoic acid resulted in an increase in cell-
associated glycosaminoglycan levels . There is a suggested 
relationship between glycosaminoglycans and external proteins such as 
the LETS protein, in that they form an extracellular complex 
responsible for cell-to-substratum adhesiveness. A retinoic acid 
binding protein was detected in the cytosol of 3T6 and 3T3 cells but 
not in 3T3SV cells, which suggested that the action of retinoic acid 
was mediated through this protein. 
Shapiro and Poon (61) reported that retinoic acid induced alterations 
in cell growth, morphology and adhesion in a human intestinal 
epithelial line (407 cell line). Their observations, however, were 
uniquely different from those reported for non-epithelial cells. In 
th i s study, growth i nh i b it i on was dependent on ce 11 dens ity, with 
greatest inhibition at low cell density and diminished inhibition at 
confluency. Cells treated with the retinoid showed increased 
detachability, while control cells grew in tight clusters with maximum 
cell to cell contact, in direct contrast to retinoid treated cells. 
Glycosaminoglycan biosynthesis was inhibited by retinoic acid. The 
authors were unable to reconcile the differences between the 
intestinal 407 cells and the data on fibroblast cell lines, but 
suggested that an intrinsic difference exists in the response of the 
two cell types towards retinoids, possibly due in some way to 
epithelial cells being the "target" cells for retinoids in. vivo. 
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With these studies providing the background information, an 
investigation of the effects of retinoid addition on the growth of 
tumour (human hepatoma and mouse melanoma) and untransformed (monkey 
kidney) cells was undertaken in this laboratory. 
MATERIALS AND METHODS 
REAGENTS 
Sodium benzylpenicillin (Novo Industries (Pharmaceuticals) (pty) 
Ltd. Johannesburg, South Africa) at 106 IU (600 mg) per vial was 
diluted to 100 ml with deionised water (together with streptomycin), 
to give a final concentration of 10 000 IU/ml. 
Streptomycin sulphate (Novo Industries (Pharmaceuticals) (Pty) 
Ltd. Johannesburg, South Africa) at 106 ~g/3 ml (per vial) was diluted 
to 100 ml with deionised water (together with penicillin), to give a 
final concentration of 10 000 pg/ml. 
Trypsin subculturing solution, in a final volume of 1000 ml, 
contained 8,0 9 NaCl, 0,4 9 KC1, 1,0 9 D-glucose, 0,58 9 
NaHC03, 0,2 9 EOTA, 0,0467 9 trypsin (500 units/ml), 0,02 9 
phenol red, 105 IU penicillin, 105 pg streptomycin. 
Phosphate buffered saline (Dulbecco's PBS without calcium or 
magnesium), in a final volume of 1000 ml, contained 
8,0 9 NaCl, 1,15 9 Na2HP04·2H20, 0,2 9 KH2P04. 
15 
0,2 9 KC1, 
Retinyl acetate stock solutions were prepared by diluting 380 ~l 
retinyl acetate (Merck, Darmstadt, West Germany) (105 IU!g) to 10 ml 
with 95% ethanol to give a 100 mM solution. Further dilutions of 
this solution were prepared in 95% ethanol to give stock solutions of 
10 mM, 5 mM and 1 mM retinyl acetate. 100 ~l of stock solution was 
added to 100 ml culture medium to prepare final working solutions of 
100 jlM, 10 jlM, 5 jlM and 1 yM, each with a final ethanol concentration 
of 0,1% (vol:vol). The preparation of vitamin A solutions was carried 
out in the absence of artificial lighting and the solutions were 
maintained in dark brown bottles at 40C. In each experiment, a 
control containing 100 ,ul 95% ethanol per 100 ml culture medium 
(0,1%) was prepared. 
MEDIA 
Eagle's basal medium (modified) (Flow Laboratories, Irvine, 
Scotland, United Kingdom) contained Hank's salts but no NaHC03. 
Each sachet was made up to a final volume of 10 with 
Milli-Q water, to which 0,5 g ascorbic acid, 0,1 g serine, 0,05 
g g lyc i ne and 7,5 g NaHC03 had been added. The med i a was 
sterile filtered through a millipore filtration unit (Millipore 
Corporation, Bedford, Massachusetts, USA) with a Sartorius prefilter 
and filters of pore sizes 0,45 pm and 0,22 pm (Millipore Corporation, 
Bedford, Massachusetts, USA) and collected in 100 ml, 250 ml and 500 
ml sterile (autoclaved) media bottles (Schott Duran, Schott Glassworks 
Mainz, West Germany). 
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Foetal calf serum (filtered and ultraviolet irradiated) (State 
Vaccine Institute, Cape Town, South Africa) was sterile filtered into 
the culture medium through a 0,45 pm Millipore filter using a Swinnex-
25 holder (Millipore Corporation, Bedford, Massachusetts, USA) . 
Growth medium was prepared by addition of 10% foetal calf 
serum and the antibiotics penicillin (500 rufml) and streptomycin 
(500 pgfml) to the minimal essential medium. This medium was used for 
experimental purposes. 
Maintenance medium containing 5% foetal calf serum and the two 
antibiotics (as above) was used to maintain cells between experimental 
periods at a slightly lower rate of proliferation. 
She lf cu lture med ium conta in ing 2% foeta 1 ca lf serum and the 
antibiotics as above, was used to maintain the survival of shelf 
cultures (at room temperature) with very little growth occurring. 
These cultures were maintained as a "backup" for a period of two to 
three weeks before being re-incubated at 37oC. 
CELL LINES 
A human hepatoma ce 11 1 i ne and an untransformed monkey kidney ce 11 
line (LLCMK) were obtained from the Department of Physiology, Medunsa, 
South Africa. A mouse melanoma cell line (BL-6) was obtained from Dr 
C. Albrecht, Department of Pharmaco logy, Un ivers ity of Ste 11 enbosch 
Medical School, Tygerberg, South Africa. The monkey kidney cell line 
was used as the non-cancerous contro 1, as th is was the on ly 
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untransformed cell line of similar histopathological origin available 
to our laboratory at that time. The culturing of untransformed 
hepatocytes and me 1 anocytes is a prob 1 emat i c undertak ing and hence 
these cell lines were unavailable for our use. 
METHODS 
Exper imenta 1 ce 11 cu lture. Procedures were carri ed out on a 
laminar flow bench using aseptic techniques. Cells were maintained in 
80 cm2 Nunc tissue culture flasks (Weil Organisation, Durban, South 
Africa) while cells for experimental purposes were cultured in 25 cm2 
Nunc tissue culture flasks. The cells were maintained at 370C in a 
Labcon forced circulation incubator Type FSIE. 
Subculturing of cells. Cells were passaged once or twice per 
week, depending on their rate of proliferation, using a trypsin 
subculturing solution. Two methods of subculturing were used: 
a) The ce 11 med ium was decanted, and 10 ml of tryps i n 
solution was sterile filtered into the flask (containing either LLCMK, 
human hepatoma or BL-6 cells). The flask was incubated at 370 C until 
the ce 11 s were removed from the flask surface and were suspended in 
the trypsin solution. Excess cells were then decanted or the entire 
cell suspension was decanted into a sterile Nunc centrifuge tube (Weil 
Organisation, Durban, South Africa) and centrifuged at 2500 g in a 
Hett i ch Uni versa 1 / K2S bench-top centri fuge for 10 mi nutes. The 
trypsin supernatant was decanted and the cell pellet was then 
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resuspended in either phosphate buffered saline (PBS) or cell medium. 
The pe 11 et was d i ssoc i ated by gent le passage through a pasteur 
pipette. This method was used mainly for routine culturing of cells. 
b) The ce 11 med i urn was decanted, and 10 ml of tryps i n 
solution was sterile filtered into the flask (containing either LLCMK, 
human hepatoma or BL-6 cells). The flask was incubated at 370C for 7 -
10 minutes (LLCMK) or 3 - 5 minutes (hepatoma or BL-6) and then most 
of the trypsin solution was decanted, leaving only a thin film of 
liquid covering the cells. The flask was then incubated at 370C until 
the cells had lifted off the flask surface. The cell suspension could 
then be reduced by decanting off the excess cell population, or the 
entire population could be removed. This procedure was used mainly 
for experimental purposes. 
Ce 11 enumerat i on. Two methods were used for determi n i ng ce 11 
number: 
a) Haemocytometry. The cells were trypsinised aseptically 
(at the start of an experiment) or under non-sterile conditions (when 
harvesting an experiment), and were then counted using a 
haemocytometer (Neubauer, West Germany). 
b) Counting Plate. Cell number was determined using a 
perspex count i ng plate devi sed by a co 11 eague (N. S. Skeef, persona 1 
communication). The plate was made to the dimensions of the 
undersurface of 25 cm2 culture flask, with perforations drawn on the 
plate wi th a need 1 e. The 1 i nes drawn were 1 mm and 0,5 mm apart as 
indicated in figure 3. A set counting pattern was followed to ensure 
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un iformity throughout. Six blocks could be counted (indicated in 
figure 3), either of size 0,5 mm X 0,5 mm (0,25 mm2) , or 1 mm X 1 mm 
(1 mm2) . The tot a 1 surface area of a sma 11 flask is 2500 mm2, hence 
counting six blocks of 0,25 mm2 required a multiplication factor of 
1666,67 and six blocks of 1 mm2 required a factor of 416,67. This 
method was found to be advantageous, in that the results obtained in 
various experiments were consistent throughout the five replicate 
flasks, as indicated by their low standard error of the mean (SEM) 
values. A further advantage when following a daily growth curve was 
that the same flask could be counted successively for six days with no 
trypsinisation r equired . 
a 
O, 5mm lmm 
E 
E 
~ 
0 
/ 
~~ 
-
3 
3 
b 
FIGURE 3. (a) Counting plate for cell enumeration (actual size). 
o indicates areas counted . (b) Enlargement of counting area . 
(N.S. Skeef, personal communication). 
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Determination of the effect of vitamin A addition on the 
proliferation of LLCMK, BL-6 and human hepatoma cells. 
a) Enumeration by haemocytometry after seven days of growth. 
Human hepatoma and BL-6 cells were seeded in 25 cm2 culture flasks at 
a concentration of 2 X 105 cells per flask, while LLCMK cells were 
seeded at 2,5 X 105 cells per flask. Five repl icates were prepared 
for each vitamin A concentration - 100 ~M, 10 ~M, 5 ~M, 1 ~M, control 
wi th ethano 1 (0,1%) and contro 1 without ethano 1. 10 m 1 of contro 1 or 
vitamin A medium containing 10% foetal calf serum and the antibiotics, 
penicillin and streptomycin (ie. growth medium), was added to each 
flask at the start of the experiment. The flasks (30 per experiment) 
were incubated at 370C. Media was replenished on day 6 and the cells 
were tryps i n i sed on day 7. Once the ce 11 s were detached from the 
flasks, the trysin solution was diluted with phosphate buffered saline 
(PBS) to a final volume of 10 ml. The number of cells per flask was 
determined using the Neubauer haemocytometer . The percentage of 
growth inhibition by retinyl acetate was calculated from the equation: 
100 - (RIC) X 100 
where R is the number of retinyl acetate-treated cells and C is the 
number of control cells (55,56,57). 
b) Enumeration by counting plate on six consecutive days. 
LLCMK cells were seeded at 2,5 X 105 cells per 25 cm2 culture flask 
and BL-6 cells at a concentration of 2 X 105 cells per flask. Five 
replicates at each vitamin A concentration (100 pM, 10 pM, 5 ~M, 1 ~M, 
control with ethanol, control without ethanol) were prepared for both 
LLCMK and BL-6 cells, while two replicates were prepared in a 
duplicate experiment with LLCMK cells only. 10 ml of control or 
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vitamin A-containing growth medium was added to each flask on day 0 
(the start of the experiment). The cells were incubated at 370C and 
after each successive 24 hour period the cell number per flask was 
determined using the counting plate. Media was replenished on day 4 
(LLCMK and BL-6) and on day 5 (BL-6 only). 
Statistical analysis. The statistical significance of 
difference was determined by the student's "t" test. 
RESULTS 
The effect of vitamin A addition on the proliferation of LLCMK, 
BL-6 and human hepatoma cells. 
a) Enumeration by haemocytometry after seven days of growth . 
The effects of vitamin A supplementation on the proliferation of the 
different cell lines studied is shown in figure 4. There is clear 
evidence of a dose-response over the range 0 - 100 ~M retinyl acetate, 
which is in accordance with work of Lotan and colleagues (3,55,56). 
The untransformed LLCMK cells el icited no significant response to 
vitamin A addition, while the growth of the tumour cell lines was 
inhibited, as summarised in Table 3. The growth of the BL-6 cells in 
particular was significantly inhibited by vitamin A addition. The 
growth of a 11 three ce 11 1 i nes appeared to be st imu 1 ated by the 
addition of the 0,1% ethanol (control) when compared to the control 
containing no ethanol. 
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FIGURE 4. The effect of vitamin A supplementation on the 
proliferation of LLCMK, BL-6 and human hepatoma cells. 
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A A BL-6 cells (b) - repeat experiment of BL-6 (a) 
0- - - - --<> Human hepatoma ce 11 s 
01 - control containing no ethanol 
02 - control with ethanol (0,1%) 
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TABLE 3. Percentage growth inhibition of cell lines at different 
vitamin A concentrations. 
---------------------------~-------------------------- ----------------
CELL LINE RETINYL ACETATE CONCENTRATION ~ 
O-EtOH O+EtOH 1 .5. .ill 100 
BL-6 (a) 0,0 9,27 38,22 60,23 71,81* 
BL-6 (b) 17,98 0,0 19,30 31,69* 38,49* 59,32* 
Human hepatoma 27,71 0,0 -46,35* 16,88 24,18 57,43* 
LLCMK 34,09 0,0 -13,64 -4,55 18,94 21,97 
* p < 0,05 when compared to the control (O+EtOH). BL-6 (b) is a 
repeat experiment of BL-6 (a). 
TABLE 4. Percentage growth inhibition of BL-6 cells at different 
vitamin A concentrations. 
----------------------------------------------------------------------
DAY RETINYL ACETATE CONCENTRATION ~ 
O-EtOH O+EtOH 1 .5. .ill 100 
3 15,47 0,0 3,23 27,71* 25,40* 52,42* 
4 7,45 0,0 8,08 37,25* 39,14* 76,00* 
5 15,38* 0,0 11 ,84 42,10* 33,19* 78,84* 
6 11,94* 0,0 8,61* 33,39* 25,48* 76,68* 
------ ------ ------ ------ ------
mean 12,56 0,0 7,94 35,11 30,80 70,99 
* p < 0,05 when compared to the control (O+EtOH). 
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b) Enumeration by counting plate on six consecutive days. 
The LLCMK cell growth curve (figure 5 a and b) shows significant 
inhibition only at a vitamin A supplementation of 100 ~M (p < 0,05). 
The growth curves for 1 ~M, 5 ~M and 10 fM closely follow those of the 
two controls, hence no significant inhibition occurred at these levels 
of vitamin A addition. 
The BL-6 cells (figure 6), however, show a significant dose-response 
over the entire range of vitamin A supplementation. Marked inhibition 
of growth occurred with the 100 ~M vitamin A-treated cells . The cells 
supplemented with 1 ~M vitamin A also elicited a reduced rate of 
growth, as did the control cells without ethanol addition (p < 0,05). 
The rate of prol iferation of the 5 ~M and 10 ~M vitamin A-treated 
cells was more significantly inhibited. 
The growth inhibition of the BL-6 cells could be quantified from day 3 
of the experiment, as indicated in Table 4. 
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FIGURE 5. LLCMK cell growth curve at various levels of vitamin A supplementation, 
(b) is a repeat experiment using two replicates, to confirm the results of (a) . 
" 
... " contra 1 (without ethano 1), 0-- o control (with ethanol), • . _. __ ._ .• 1 flM vitamin A, 
0----0 5 pM vitamin A, A---'-A 10 pM vitamin A,. • 100 pM vitamin A. 
'" 
'" 
3,2 
3,0 
2,8 
2,6 
2,4 
~ 2,2 
., 
I 2,0 0 
~ 
x 
~ 1,8 
a: 
I1J 
III 1,6 
:::< 
::l 
z 1,4 
..J 
..J 
I1J 1,2 0 
1,0 
0,8 
0,6 
0,4 
0,2 
0 
1 2 3 4 
TIME (day.) 
~' .... 
':4' 
1/ 1 
i/ 
I:' 
5 
/1 
6 
FIGURE 6. BL-6 cell growth curve at various levels of vitamin A 
supplementation . 
c, . c, contro 1 (without ethano 1), 0 ---0 contro 1 (with ethanol), 
• . - -. 1 flM vitamin A, o-----{] 5 flM vitamin A, "'.--_ ... • 10 pM 
vitamin A, • --. 100 pM vitamin A. 
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DISCUSSION 
Enumer ation of cell growth by haemocytometry showed a slight, but non-
s i gnifi cant, inhibition of LLCMK growth at 10 pM vitamin A 
supplementation and in the control without ethanol, while 1 pM and 5 
pM vitamin A supplementation appeared to elicit a slight, but non-
signif i cant, stimulat i on of LLCMK cell growth. Cell growth 
determination using the counting plate also showed no significant 
inhibition of LLCMK cell growth when treated with 1 pM, 5 pM and 10 ~M 
vitamin A and in the control without ethanol. It is evident from 
these experiments that retinyl acetate appears to have little effect 
on the proliferation of LLCMK cells in vitro up to a concentration of 
10 pM . 
The LLCMK growth curve consisting of five replicates at each vitamin A 
concentration (figure 5 a) was not conclusive on its own, as the six 
concentrations were not set up on the same day. The two controls and 
the 1 pM vitamin A-treated cells were set up on a different day to 
the 5 pM, 10 pM and 100 pM vitamin A-treated cells, and hence the 
cells in the two parts of the experiment could easily have been at 
different stages of growth and exposed to sl ightly different 
conditions. The experiment was set up in this manner due to the 
difficulty in counting the cells from the entire experiment at one 
s itt ing. The s 1 i ght ly lower counts on day 1 for the latter ha If of 
the experiment indicated that these cells may have undergone slightly 
more harsh treatment at the start of the experiment, as all the LLCMK 
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cells were initially seeded (day 0) at the same starting 
concentrat i on. The growth curves at different vitami n A treatments 
could thus not be conclusively compared. 
This problem was not encountered with the BL-6 growth curve (figure 6) 
as the cells at all six vitamin A concentrations were seeded on the 
same day and hence under similar growth conditions. In this case, the 
exper iment was set up in two halves, wi th approx imate ly a two hour 
break in between. On counting the cells each day, this two hour break 
between the two halves was maintained in order to ensure uniformity. 
The two hour break enabled effective counting of all the replicates on 
the same day. The experiment was set up in this manner to eliminate 
the problem encountered in the initial experiment with the LLCMK cells 
above . 
I n order to e 1 imi nate the uncerta i nty of the data with the LLCMK 
cells, a duplicate experiment was set up. Here, all cells 
supplemented with the various concentrations of vitamin A were seeded 
on the same day and hence under similar growth conditions. Only two 
replicates were used at each vitamin A concentration, since this was a 
repeat experiment designed to confirm the previous experiment. The 
resulting growth curve (figure 5 b) was similar to that obtained in 
the first experiment and allowed a conclusive deduction to be made, 
namely that vitamin A supplementation up to a concentration of 10 pM 
appeared to have little effect on the proliferation of LLCMK cells. 
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The tumour ce 11 1 i nes BL-6 and human hepatoma, however, eli cited a 
sign if i cant dose-response to ret iny1 acetate supp 1ementat ion. The 
significant (p < 0,05) inhibition of BL-6 cell growth at 1 pM vitamin 
A supplementation was an important observation, as in in vivo systems 
the plasma concentration of vitamin A is approximately 1 pM (2,11,22-
24,31-35) . At higher (non-toxic) vitamin A concentrations (5 pM and 
10 ~M), there was an even greater inhibition of BL-6 cell growth. The 
difference between the effect of 5 ~M and 10 ~M vitamin A on 
inhibition of BL-6 cell growth was not significant. 
The use of the haemocytometer (figure 4 and Table 3), however, did not 
produce results which were as statistically significant as those 
resu 1 ts determined by the count i ng plate (fi gure 6 and Tab 1 e 4). 
Although the trends of tumour cell growth inhibition using the 
haemocytometer were clearly evident (figure 4), the differences 
between the cell numbers compared to the contro 1 were not a 1ways of 
statistical significance (Table 3). The inhibition of BL-6 cell 
proliferation is in accordance with work of Lotan and colleagues who 
found a 48% growth inhibition in BL-6 cells treated with 10 pM retiny1 
acetate (3,55,56). A greater inhibition of cell growth with 
increasing vitamin A supplementation has previously been reported by a 
number of researchers, working with a variety of different cell lines 
and different forms of vitamin A (55-60), as summarised in the 
introduction to this chapter. 
The human hepatoma cells elicited a significant (p < 0,05) stimulation 
of growth when supplemented with 1 pM vitamin A. This level of 
vitamin A supplementation thus appeared to be the optimum for 
30 
proliferation of human hepatoma cells. At 5 ~M and 10 ~M vitamin A 
supplementation the inhibition of cell proliferation was not 
significant when compared to the control (with ethanol). However, 
when compared to the proliferation of the 1 ~M vitamin A-supplemented 
cells, a substantial inhibition of growth was observed in both the 
5 pM and 10 pM vitamin A-treated hepatoma cells. This indicates that 
the two transformed cell lines in this study elicit slightly different 
responses at low non-toxic levels of vitamin A supplementation. 
The addition of 100 pM vitamin A to both the tumour and untransformed 
cells resulted in significant inhibition of proliferation (p < 0,05). 
This could be due to cytotoxicity, as the cells, when viewed under the 
opt i ca 1 mi croscope, did not appear to be ina norma 1 hea lthy state . 
Many of the cells had detached from the flask surface, while others, 
which were still attached, appeared to have a "granular" appearance. 
Th i s was one of the factors that prompted further invest i gat ion of 
these effects using ultrastructural techniques (chapter 3). 
As the retinyl acetate was made up in ethanol (final concentration in 
the cell media of 0,1%) the control cultures were those supplemented 
with 0,1% ethanol and hence the counts of the vitamin A-treated cells 
were compared to the counts of th i s contro 1. I t appears that the 
addition of 0,1% ethanol to the cell media resulted in a slight 
stimulation of cell growth, this effect being more pronounced in the 
tumour cells. This was in contrast to the results of Findley, 
Steuber, Ruymann, Culbert and Ragab (62) who found no effect of 0,04% 
ethano 1 on bone marrow and 1 eukemi a ce 11 s. The st imu 1 at i on of ce 11 
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growth by the ethanol administration did not, however, mask the 
inhibitory effects of vitamin A on the tumour cells. 
Figure 5 (a and b) and figure 6 show a similar phenomenon whereby the 
number of ce 11 s seeded per fl ask (day 0). whether untransformed or 
tumour cells, exceeded the number of cells determined on day 1. This 
indicates that a percentage of the cells did not withstand the harsh 
procedures of trypsinisation, centrifugation and the passage through a 
pasteur pipette (for dissociation of the cell pellet) associated with 
the preparat i on of the ce 11 sus pens i on. Us i ng the count i ng plate 
technique, the cell number in a large (80 cm2) culture flask (for 
seeding of an experiment) was determined prior to trypsinisation, and 
hence when these cells were removed from this flask a certain 
percentage of cells were obviously lost, thus contributing to the 
reduction in cell number. This did not pose a serious problem, 
however, as the most essential factor was ensuring that each flask in 
the experiment was seeded with a constant cell population. 
The determination of the extent of inhibition using either 
haemocytometry on the seventh day of growth or enumeration by counting 
plate on six consecut i ve days, produced simi 1 ar trends in BL-6 ce 11 
growth as can be seen by a compar i son of resu lts in Tab les 3 and 4. 
It is evident by comparing figure 4 to figure 5 and figure 6 that 
results were more conclusive when cell number was determined by 
counting plate rather than by haemocytometry. The most striking 
difference between the results using the two techniques was the size 
of the SEM (standard error of the mean) bars, and hence resu lts 
achieved by counting plate can be discussed with more conviction than 
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those determined by haemocytometry. A further limitation in the use 
of the haemocytometer was the determination of very low cell number. 
In particular, for example, was the case of the LLCMK cells treated 
with 100 ~M vitamin A. The multiplication factor in haemocytometry is 
104 (for the number of cells/mll, whereas the factor is 416,67 or 
1666,67 (for tota 1 ce 11 number) when us i ng the count i ng plate, and 
this certainly influenced the results when only a few cells were 
enumerated. Hence, for the LLCMK ce 11 s, haemocytometry of 100 ~M 
vitamin A supplementation showed a 21,97% (Table 3) growth inhibition 
(which was not statistically significantly different from the 
control), whereas the counting plate elicited a 49,17% growth 
inhibition (figure 5b) which was statistically significantly different 
(p < 0,05) from the control. It would appear, therefore, that the 
more reliable and consistent data was that obtained using the counting 
plate. 
In conclusion, significant inhibition of malignant BL-6 but not of 
untransformed LLCMK cell growth was found with the addition of 
physiological (non-toxic) levels of vitamin A (1 - 10 ~M) to in vitro 
cultures of these cells. Addition of 100 }1M vitamin A resulted in 
significant inhibition of all three cell types (BL-6, human hepatoma 
and LLCMK), which may possibly be due to a cytotoxic effect, 
particularly since the cells appeared to have undergone certain 
ultrastructural changes as a result of this treatment. In order to 
investigate the possible effect of vitamin A addition on 
the ultrastructure of the cells, electron microscopy studies were 
undertaken. 
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CHAPTER 3 
ULTRASTRUCTURAL OBSERVATIONS OF VITAMIN A-TREATED CELLS BY 
TRANSMISSION ELECTRON MICROSCOPY 
I NTRODUCTI ON 
Vitamin A plays a key role in vision, reproduction, bone growth and 
epithelial development (1,3,5,6,18) . A well established function of 
vitamin A is its role in the ultrastructural development of cells. 
Cell membrane integrity is known to be dependent on vitamin A (1,3) 
and of particular importance is the cell surface (plasma) membrane. 
Some of the effects of v itami n A, such as those re 1 ated to ce 11 
adhesion and cell-cell interaction, appear to be exerted on the plasma 
membrane directly without nuclear interaction (1,63) while other 
effects are mediated through the nucleus (1,64) (discussed further in 
chapter 4). 
An electron microscopy study was undertaken by Matter and Bollag (65) 
to investigate the effect of a retinoic acid analogue on chemically 
induced papillomas in mouse skin. They found a marked enhancement of 
proteog lycan product ion and secret i on into the extrace 11 u I ar space, 
lab iIi sat ion of the plasma membrane resu It i ng in vacuo 1 i sat i on and 
loss of cytoplasmic constituents, an increase in lysosomal organelles 
and the format i on of many necrot i c ce 11 s. They proposed that ce 11 
necrosis was due mainly to labilisation of the plasma membrane and, 
together with the enhanced proteoglycan production and secretion, this 
34 
was responsible for the observed regression of the papi llomas on 
treatment with the retinoid. 
Prompted by this knowledge, together with the observation of a 
"granu 1 ar" appearance of vi tami n A-treated ce 11 s under the opt i ca 1 
mi croscope (chapter 2), an u ltrastructura 1 study of the effects of 
vitamin A supplementation on both cancer and untransformed cells was 
undertaken. This was in an attempt to identify a possible mechanism 
of action of vitamin A, to account for the reduction in tumour cell 
growth observed earlier (chapter 2). 
MATERIALS AND METHODS 
REAGENTS 
Retinyl acetate stock solutions as prepared in chapter 2. 
Trypsin subculturing solution as prepared in chapter 2. 
a) Transmission electron microscopy 
Phosphate buffer (0,1 M at pH 7,3) (66) was prepared by mixing 
eight parts of solution 1 and two parts of solution 2: 
Soln . 1: 35,814 g Na2HP04·12H20 / 1 
Soln. 2: 13,610 g KH2P04 / 1 
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Glutaraldehyde (5% solution) (66) was prepared by diluting 20 ml 
of 25% glutaraldehyde (ultrastructural grade) to 100 ml with phosphate 
buffer. 
Osmium tetroxide (Millonig, 1% solution) (66) consisted of D,S g 
Os04, 45,0 ml solution D and 5,0 ml solution C, adjusted to pH 7,3 (if 
necessary, with 0,1 N HC1) and stored in tightly stoppered dark 
bottles at 40C. 
Soln . A: 
Soln. B: 
Soln. C: 
Soln. D: 
2,26% NaH2P04·H20 
2,52% NaOH 
5,40% glucose 
41,S ml soln. A 
8,5 ml soln. B 
Ethanol (95%) (66) was diluted with 
30% 160 ml 95% EtOH + 340 ml 
50% 260 ml 95% EtOH + 240 ml 
70% 370 ml 95% EtOH + 130 ml 
80% 420 ml 95% EtOH + 80 ml 
90% 475 ml 95% EtOH + 25 ml 
distilled water as follows: 
H2O ~ 500 ml 30% EtOH 
H2O ~ 500 ml 50% EtOH 
H2O ~ 500 ml 70% EtOH 
H2O ~ 500 ml 80% EtOH 
H2O ~ 500 ml 90% EtOH 
Embedding medium used was Taab 812/Araldite (R.H.M. Cross, 
personal communication). 
Toluidine Blue stain (66) was prepared by dissolving 0,1 g 
toluidine blue powder in 10 ml sodium carbonate (2,5 g sodium 
carbonate in 100 ml distilled water). 
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Uranyl acetate stain (66) was prepared by dissolving 0,25 g 
uranyl acetate powder in 5 ml distilled water and mechanically shaking 
the mixture for 30 minutes (suitable for use for 24 hours). 
Lead citrate stain (Reynolds) (66) was prepared by dissolving 
0,44 g lead nitrate and 0,59 g sodium citrate in 10 ml distilled 
water. The solution was violently shaken for 1 minute and then 
mechanically shaken for 30 minutes. 2,6 ml fresh 1,0 M NaOH was 
added, the mixture was gently agitated until the cloudiness 
disappeared and then 4,0 ml distilled water was added. 
b) Lipid determination 
Ethanol (30% and 70%) were prepared as above. 
Sudan lY. (Scarlet Rl (67) was prepared by dissolving 0,25 g 
Sudan IV powder in 50 m 1 70% ethano 1 ina warm water bath and then 
filtering the solution. 
Formalin (100% formaldehyde) was diluted to a 10% solution with 
0,9% saline. 
Mayer's Hematoxylin (Mallory) (68) was prepared by gently 
heating 1 g hematoxylin in 1000 ml distilled water. 0,2 g sodium 
iodate and 50 g potassium alum (KA1(S04)2"12H20) were added and the 
solution was heated until dissolved. 1 9 citric acid and 50 g chloral 
hydrate were added and the preparation was allowed to ripen for 6 - 8 
weeks before use. 
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Farrant's medium containing glycerin, arsenious acid and gum 
arabic (exact composition unknown) was the water soluble mounting 
medium used . 
METHODS 
a) Transmission electron microscopy 
Preparation of vitamin A-treated LLCMK, human hepatoma and BL-6 
cells for transmission electron microscopy . LLCMK, human hepatoma and 
BL-6 cells were seeded at 2,5 X 105, 2,0 X 105 and 3,0 X 105 cells per 
25 cm2 flask, respectively. Vitamin A-containing growth medium was 
prepared at concentrations of 100 )-1M, 10 jlM, 5 )-1M, 1 }JM retinyl 
acetate and a control with ethanol (0,1%) . The cells were incubated 
at 370C with 10 ml of medium per flask. Medium was replenished on day 
3 (BL-6 cells only) and day 6 (all cell lines) and the cells were 
trypsinised on day 7. The three cell lines were treated in the same 
manner in preparat i on for electron mi croscopy . The ce 11 suspens ions 
(in trypsin) were centrifuged in a Beckman microfuge B (California, 
USA) for 3 minutes . Each pellet was resuspended in media to rinse off 
the trypsin, and then microfuged again . Each cell pellet then 
underwent fixation and embedding (as below, R.H.M. Cross, personal 
communication). 
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Fixation and embedding protocol 
Pre-fix: 5% glutaraldehyde 
Wash : Phosphate buffer (0,1 M, pH 7,3) 
Secondary fix: Os04 
Wash: Phosphate buffer (0,1 M, pH 7,3) 
30% EtOH 
50% EtOH 
70% EtOH 
80% EtOH 
90% EtOH 
abs EtOH 
abs EtOH 
propylene oxide 
propylene oxide 
75:25 pro:resin 
50:50 pro:resin 
25:75 pro:resin 
pure resin 
pure resin in moulds 
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Minutes 
overnight 
10 (X 2 washes) 
90 
10 (X 2 washes) 
5 
5 
5 
5 
5 
5 
5 
15 
15 
60 
75 
75 
overnight 
36 hrs at 600C 
Preparat ion of glass kn ives was accordi ng to the procedure of 
R.H.M. Cross (66). These glass knives, however, were not satisfactory 
as the cell pellet appeared to contain some crystalline material which 
chipped the cutting edge of the glass knives, resulting in unsightly 
marks and the cutting of uneven sections. Hence, a diamond-edged 
kn ife was used on the LKB U ltrotome II I u ltrami crotome (Stockho 1m, 
Sweden) for cutting of the ultrathin sections. 
Preparation of thick sections for optical microscopy and 
ultrathin sections for transmission electron microscopy . Thick 
sections (2 - 3 pm) were initially cut from the specimens and stained 
with toluidine blue for examination under the optical microscope. 
Ultrathin sections of the desired thickness (40 - 50 nm) were cut and 
appeared silver when ref lected through the mi croscope. The sect ions 
were floated onto a water surface and collected on copper grids of 300 
mesh (300 holes/inch). The sections on the grids were stained with 
the heavy metal stains uranyl acetate (30 minutes) and lead citrate (5 
minutes) . The LLCMK and human hepatoma cells were examined on the 
JEOL JEM 100 ex II transmission electron microscope (Tokyo, Japan) at 
an acceleration voltage of 80 KV, while the BL-6 cells were examined 
on the Hitachi HU 11B transmission electron microscope (Tokyo, Japan) 
at an acceleration voltage of 50 KV. (The JEOL JEM 100 ex II electron 
microscope was not operational at the time of the BL-6 study.) 
Photographs (us ing I lford electron mi croscopy film) were taken of 
various sections and developed by the staff of the Electron Microscopy 
Unit, Rhodes University, Grahamstown, South Africa. 
40 
b) Lipid determination 
Preparation of vitamin A-treated LLCMK and BL-6 cells for lipid 
determination. 80 cm2 tissue culture flasks were used in the 
preparat ion of LLCMK and BL-6 ce 11 s for 1 i pi d determi nat i on. Both 
cell types were grown in media containing 100 pM retinyl acetate. The 
ce 11 s were rna i nta i ned unt i 1 conf 1 uency (ret i no i d-med i urn be i ng 
replenished as required), and were then trysinised and centrifuged. 
The pellets were gently resuspended in 10% formalin (in 0,9% saline) 
and allowed to fix for 4 hours. The ce 11 suspens ions were aga i n 
centrifuged and the formalin decanted . 
Preparation and staining of microtomy sections for optical 
microscopy. The ce 11 pe 11 ets were transferred onto a freez i ng 
microtome (Reichert, Austria) and 10 - 50 pm sections were cut and 
transferred onto glass microscope slides. The slides were allowed to 
dry in a 370C oven. The sections were stained (67) in Sudan IV (0,5% 
in 70% ethanol) for 15 minutes and then rapidly washed in 70% and 30% 
ethanol (2 minutes in each solution). The sections were washed in 
distilled water, stained in Hematoxylin for 8 minutes and then washed 
well in distilled water. Farrant's medium was used as the water 
soluble mounting medium over which the glass coverslips were placed . 
The slides were allowed to air dry and the sections were then examined 
and photographed using a Zeiss photomicroscope (Zeiss, Germany). 
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RESULTS 
a) Transmission electron microscopy 
Ultrastructural observation indicated what appeared to be a few small 
lipid droplets located within the control human hepatoma cells (figure 
7) and the control BL-6 cells (figure 8) . A similar occurrence of a 
few small lipid droplets was found in the control LLCMK cells (figure 
9). In both human hepatoma and LLCMK cells, treatment with 1 )1M 
vitamin A did not appear to effect the ultrastructure of the cells, as 
their appearance was similar to that of the respective controls. 
Consequently, the electron micrographs at this level of vitamin A 
treatment are not shown. 
The supplementation of 5 )1M vitamin A to the LLCMK cells appeared to 
have no ultrastructural effect on these cells (figure 10), however, 
the same vitamin A supplementation to human hepatoma cells resulted i n 
the increase ins i ze of what were suspected to be 1 i pi d drop 1 ets, 
accompan ied by vacuo 1 at i on and the start of ce 11 breakdown (f i gure 
11) . Prob 1 ems were encountered wi th the sect ion i ng of the 5 ,uM 
vitamin A-treated BL-6 cells and hence micrographs at this level of 
v itami n A are not shown . The addition of 10 ,11M vitamin A to the 
human hepatoma and LLCMK cells elicited similar ultrastructural 
responses to those observed in the 5 ,11M vitamin A-treated hepatoma and 
LLCMK cells respectively, and as a result these micrographs are again 
not shown. 
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FIGURE 7. Transmission electron micrographs of control human hepatoma cells . 
L = lipid droplet, N = nucleus, E = endoplasmic reticulum, M = mitochondria. Bar represents 1 ~m. 
(V') 
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FIGURE 8. Transmission electron micrographs of control BL-6 cells. 
L = lipid droplet, N = nucleus, M = mitochondria, G = Golgi body. Bar represents 1 ~m. 
o::f' 
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FIGURE 9. Transmission electron micrographs of control LLCMK cells. 
L = lipid droplet, N = nucleus, M = mitochondria, G = Golgi body. Bar represents 1 ~m. 
I,{) 
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FIGURE 10. Transmission electron micrograph of an LLCMK cell 
supplemented with 5 ~M vitamin A. 
L = lipid droplet, M = mitochondria. Bar represents 1 pm. 
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FIGURE 11. Transmi ss ion electron mi crograph of a human hepatoma 
cell supplemented with 5 ~M vitamin A. 
L = lipid droplet, V = vacuole. Bar represents 1 ~m. 
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The human hepatoma and BL-6 cells treated with 100 ~M vitamin A were 
found to have accumulated a great number of large lipid droplets which 
appeared to extend throughout the cell interior (figure 12 and 13 
respect i ve ly). A further observation was that numerous tumour ce 11 s 
treated with this level of vitamin A appeared to be in various stages 
of degeneration (figure 14). 
The effect of 100 pM vitamin A supplementation on the LLCMK cells 
(figure 15) was an observed increase in the number and size of the 
1 i P i d drop 1 ets (compared to contro 1 ce 11 s) I as we 11 as a number of 
ce 11 s at various stages of cell degeneration. However I the general 
effect was not as marked as that found with the tumour cells. 
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FIGURE 12. Transmission electron micrographs of human hepatoma cells supplemented with 100 ~M vitamin A. 
L = lipid droplet, M mitochondria, E = endoplasmic reticulum. Bar represents 1 ~m. 
en 
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FIGURE 13. Transmission electron micrographs of BL-6 cells supplemented with 100 pM vitamin A. 
L = lipid droplet, N = nucleus, M = mitochondria. Bar represents l~m. 
o 
If) 
FIGURE 14. Transmission electron micrograph of cell degeneration in 
a human hepatoma cell supplemented with 100 ~M vitamin A. 
L = lipid droplet, D = degeneration of cellular constituents, 
P = periphery of former cell. Bar represents 1 ~m. 
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FIGURE 15. Transmission electron micrographs of LLCMK cells supplemented with 100 pM vitamin A. Cellular 
N 
UI 
degeneration is apparent in these micrographs. L = lipid droplet, N = nucleus, G = Golgi body. Bar represents 1 ~m. 
b) Lipid determination 
Optical microscopy of the LLCMK and BL-6 cells which were treated 
with 100 )1M vitamin A, sectioned and then stained with Sudan IV I 
revea 1 ed that the red 1 i P i d sta i n had been taken up by both ce 11 
types. The two cell types were indistinguishable under the optical 
microscope and thus only the stained BL-6 cell sections are shown 
(figure 16). This indicated that the droplets observed under 
transmission electron microscopy were indeed of a lipid nature. 
L L 
FIGURE 16. Sudan IV lipid staining of cell sections. 
L = lipid droplet. Bar represents 10 ~m. 
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DISCUSSION 
The results obtained from the electron microscopy study correlate well 
with the cell growth results in chapter 2. 
There appeared to be 1 itt le ultrastructura 1 difference between LLCMK 
control cells (figure 9) and the LLCMK cells treated with 1 ~M, 5 ~M 
(figure 10) and 10 ~M vitamin A. This correlates with the cell growth 
results where the cell counts (determined both by haemocytometry and 
counting plate) for 1 ~M, 5 ~M and 10 ~M vitamin A-treated cells were 
not significantly different from those of the control LLCMK cells. 
The difference between the human hepatoma control cells (figure 7) and 
those cells treated with 5 ~M vitamin A (figure 11) is clearly 
evident. The size of the lipid droplets has increased markedly as has 
the extent of vacuolation, preceeding the breakdown of the cell. The 
differences indicated here reflect the earlier differences obtained in 
cell counts between the control and 5 ~M vitamin A-treated hepatoma 
cells. 
The supplementation of 100 ~M vitamin A to LLCMK (figure 15), human 
hepatoma (figure 12) and BL-6 (figure 13) cells has marked 
u ltrastructura 1 effects. A 11 three ce 11 types showed an increase in 
the number and size of the lipid droplets compared to the respective 
controls. The effect was far greater in the tumour cells, where the 
cell interior consisted mainly of the large lipid droplets. The ratio 
of lipid droplet size to cell size was very much lower in the LLCMK 
cells than the tumour cells . Extensive cell degeneration was apparent 
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in all three cell types treated with this high vitamin A dose. This 
is in agreement with the resu lts in chapter 2 (fi gure 4, 5 and 6) 
where all three cell types showed marked inhibition of growth at this 
level of vitamin A treatment. It appears that at this leve l, the 
vitamin A has a cytotoxic effect on both untransformed and tumour 
ce 11 s. 
It has previously been suggested that possible mechanisms of 
inhibition of tumour cell growth by vitamin A supplementation may be 
through a disturbance of metabol ic functioning of the cell (69,70) or 
through a disruption of the cell membrane (1,3,65). A possible 
disruption of cell function through lipid accumulation was observed in 
this study. It would appear that the fat-soluble vitamin A, since it 
can readily pass through the lipid membrane of the cell (1), may be 
accumulating in the lipid droplets described above . The lipid nature 
of these droplets was confirmed by Sudan IV staining (figure 16). A 
similar observation of lipid accumulation was found by Robinson, Bux 
and Botha (69,70), when human oesophageal and breast cancer cell lines 
were treated with the fatty acid, gamma-linolenic acid. 
At low vitamin A concentrations the cells may effectively metabolise 
part or all of the lipid-soluble vitamin. This capacity for 
metabolism of the fat-soluble vitamin A may vary between different 
ce 11 1 i nes and may be higher in untransformed ce 11 s than in tumour 
cells. This may explain the difference in l ip id accumulation between 
the untransformed cells (figure 10) and the tumour cells (figure 11), 
at a level of vitamin A supplementat ion of less than 10 JIM in this 
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study. This in turn may partly explain the difference in inhibition 
of growth of the tumour but not the untransformed cells at this level 
of vitamin A supplementation. At a higher le vel of vitamin A 
supplementation, however, the amount of vitamin A and lipid 
accumulation may far exceed the metabolic capacity of the cells . This 
may more drastically disrupt the metabolic functioning of the cells, 
resulting in a decreased proliferation of both tumour and 
untransformed cells. More detailed studies will, however, be requ ired 
to substantiate this proposal. 
The cell degeneration observed to a limited extent at low levels of 
vitamin A supplementation but very apparent, particularly in the 
tumour cells, at the cytotoxic level (100 ~M) of vitamin A, may be due 
to a disruption of metabolic functioning of the cells, as a result of 
the lipid accumulation, or may be the result of a more direct effect 
of vitamin A supplementation on cell membrane structure and function. 
This cell degeneration would also account for the more marked effect 
of higher levels of vitamin A supplementation on the rate of 
proliferation of the different cell types. 
The possible effect of vitamin A supplementation on cell membrane 
structure and function, and in particular, its involvement in 
fibronectin synthesis and release, will be examined in the next 
chapter. 
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CHAPTER 4 
EFFECT OF VITAMIN A ADDITION ON THE RELEASE OF FIBRONECTIN BY 
CULTURED CELLS USING AN ELISA SYSTEM 
r NTRODUCTI ON 
Fibronectins are high molecular weight glycoproteins (71-74) that are 
present on many cell surfaces, in extracellular fluids, in connective 
tissue matrices and in most basement membranes (72-75). The various 
forms of fibronectin have previously been known by a number of 
different terms, including LETS protein (large external 
transformation-sensitive protein), CSP (cell surface protein), Crg 
(cold-insoluble globulin), CAF (cell adhesion factor) and various 
others (74-77). Fibronectins have been implicated in a variety of 
cell properties, such as cell adhesion, morphology, cytoskeletal 
organisation, migration, differentiation and oncogenic transformation 
(73) . 
Fibronectins are composed of similar polypeptide subunits of 220 000 -
250 000 Da that are linked by disulphide bridges into dimers and 
multimers (71-74,78,79) . The cellular and plasma forms of fibronectin 
are similar but not identical in structure and function. Plasma 
fibronectin appears to be a dimer while cellular fibronectin occurs 
both as dimers and multimers (72,74,78,80). 
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The various domains of fibronectin contain the different binding 
functions of the molecule, including heparin, fibrin, collagen and 
ce 11 bind i ng regi ons. These doma i ns are protease res i stant and are 
linked by flexible protease susceptible polypeptide regions 
(73,78,79). Fibronectin contains approximately 5% carbohydrate, 
consisting mainly of complex oligosaccharides linked to asparagine 
residues (73,75,78). The carbohydrate moiety was suggested to have no 
major function in secretion of fibronectin, and no detectable effect 
on a number of the biological activities of the molecule (78). The 
primary function of the carbohydrate moiety appears to be the 
stabilisation of specific regions against proteolytic attack 
(73,75,77,78). 
A characteristic common to many transformed cells is a decrease in the 
amount of surface-associated fibronectin (75,80-82). A number of 
studies have demonstrated the role of fibronectins in restoring normal 
morphology, adhesion and cytoskeletal arrangement of cultured cells in 
vitro. 
Yamada, Yamada and Pastan (83) isolated CSP (cell surface protein) 
from chick embryo cells by urea extraction. They found that the 
protein had agglutinating activity, was sensitive to protease 
digestion and required divalent cations for activity. They therefore 
suggested that the molecule played a role in cell adhesion. 
In another study, Yamada, Yamada and Pastan (84) added the isolated 
CSP to a variety of transformed cells in vitro (SVT2, NRK and L929 
cells). The cells became elongated and flattened and these 
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morphological changes were antagonised by addition of an antibody to 
esp. The ce 11 s showed increased adhes i on to the substratum and a 
restoration of contact inhibition on addition of esp . 
Ali, Mautner, Lanza and Hynes (85) added LETS glycoprotein, which was 
isolated from normal (NIL) cells, to transformed cells (HSV-
transformed NIL). They found that certain morphological features and 
adhesive properties were restored in the transformed cells. In 
addition, a fibrillar network on the cell surface and the arrangement 
of actin in cables was also observed in the LETS-treated transformed 
ce 11 s. 
Ali and Hynes (86) observed an increase in mi grat i on of both norma 1 
and transformed cells on the addition of LETS glycoprotein. The 
glycoprotein attached to the cells in a fibrillar network and binding 
was greater to normal than to transformed cells. 
Yamada, Olden and Pastan (77) isolated and purified esp from chick 
embryo fibroblasts and added the protein to 14 transformed cell lines 
from several different species (chicken, hamster, mouse, rat and 
human). The results indicated a reversion to a more normal 
fibroblastic morphology, adhesiveness, cell surface architecture, 
microfilament bundle organisation, motility and alignment at 
conf 1 uence. The authors suggested that the effects of esp appear to 
be due to at least two actions, namely increased cell-substratum 
adhesion and altered cell-cell interactions. 
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Smith, Riggs and Mosesson (87) examined various human epithelial cell 
lines for their expression of fibronectin . In the cell lines derived 
from nonmalignant tissues or from primary carcinomas, fibronectin was 
found predominantly in an extracellular matrix, while fibronectin was 
marked ly reduced or absent from extrace 11 u 1 ar matri ces ina 11 ce 11 
lines derived from metastatic carcinomas. 
Hassell, Pennypacker, Kleinman, Pratt and Yamada (88) investigated the 
mechanism of fibronectin accumulation by control and vitamin A-treated 
ch i ck sterna 1 chondrocytes. They found that contro 1 chondrocytes, 
wh i ch 1 ack f i bronect in as a surface protei n, synthes i sed a lmost as 
much f ibronect in as vitami n A-treated chondrocytes (wh i ch conta i ned 
cell surface fibronectin), but that it was secreted primarily into the 
culture medium. Although the fibronectin of the control chondrocytes 
had a slightly lower molecular weight than that synthesised by the 
vitamin A-treated cells, it bound to the cell surface of both normal 
and treated cells. The vitamin A-treated cells, however, were more 
effective in binding fibronectin synthesised by either control or 
treated ce 11 s. The authors thus proposed that in chondrocytes, 
vitamin A appears to regulate the cellular accumulation of fibronectin 
by increasing the ability of the cell surface to bind fibronectin 
rather than by altering its synthesis. It appears that the synthesis 
or availability of a specific receptor for fibronectin, which is 
lacking in chondrocytes, is stimulated by the addition of vitamin A. 
The authors suggested that the smaller molecular size of the 
fibronectin in the control chondrocytes may be due to incomplete 
processing which results in an immature fibronectin. They suggested 
that retinyl phosphate (a vitamin A derivative) may act as a lipid 
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intermediate in glycosy1ation of fibronectin, thus producing a mature 
fibronectin of proper molecular size in the vitamin A-treated 
chondrocytes. 
Vitamin A is known to playa role in glycoprotein synthesis (1-3,89) . 
Both retinol and a hydroxy1ated retinoic acid metabolite can be 
phosphorylated and then reacted with a monosaccharide such as mannose 
to form a glycosy1 (mannosy1) retiny1 phosphate (1-3,14). This 
conjugate is then able to transfer the monosaccharide via a 
glycosy1transferase to a macromolecular glycoprotein acceptor (such as 
fibronectin). This reaction takes place in the cell membrane thus 
allowing the glycosy1ation of membrane glycoproteins in situ (3). 
Tumour promoters such as 12-tetradecanoy1phorbol-13-acetate (TPA) 
e1 icit a range of biochemical responses in cells in vitro, many of 
wh i ch mimi c those observed in cancer or transformed ce 11 s . Such 
responses include · decreased cell-substratum adhesion, changes in cell 
surface glycoproteins and loss of cell surface fibronectin (90,91). 
Retinoids are known to inhibit many of these TPA-induced effects 
(90,91). This prompted Bo1mer and Wolf (63) to study the effects of 
TPA and retinoid addition on the loss of fibronectin from cultured 
mouse 3T3 cells . They found that addition of TPA induced the release 
of fibronectin from 3T3 and enucleated 3T3 cells into the media. This 
TPA-induced fibronectin release was inhibited by retinoic acid and 
retinoic acid derivatives in a dose-dependent manner in both 3T3 and 
enuc 1 eated 3T3 ce 11 s. They conc 1 uded that at least one aspect of 
tumour promotion induced by phorbo1 esters, namely the loss of 
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f i bronect in, does not requ ire the presence of the ce 11 nuc 1 eus and 
further that retinoids can inhibit this aspect of tumour promotion 
without nuclear involvement . 
A study by Kim and Wo If (64) was undertaken to determi ne whether a 
nuclear or extranuclear mechanism was i nvolved in the interaction of 
vitamin A and fibronectin. They found that vitamin A appears to 
regulate the synthesis of fibronectin through its action on 
fibronectin mRNA transcription, and propose this to be the first 
reported observation of an action of vitamin A at the genomic level on 
the synthesis of a specific protein . Thus, from the same laboratory, 
we have evidence of vitamin A affecting fibronectin metabolism through 
both a nuclear and an extranuclear mechanism. 
It is thus clear that the absence or presence of vitamin A in varying 
amounts could have a direct effect on membrane glycoproteins. Of 
particular importance in this study was the effect of vitamin A on the 
specific glycoprotein, fibronectin, the synthesis and secretion of 
wh i ch, as descr i bed above, is an important factor in the deve lopment 
and growth of transformed cells. The effect of vitamin A on the 
release of fibronectin was investigated using only the LLCMK and BL-6 
ce 11 s, as the human hepatoma ce 11 1 i ne became contami nated and was 
unavoidably lost. A further supply of the cell line was unavailable. 
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MATERIALS AND METHODS 
REAGENTS 
Retinyl acetate stock solutions as prepared in chapter 2, . 
Sodium carbonate buffer (0,05 M, pH 9,6) containing 0,02% sodium 
azide was prepared by adding 66,6 ml Na2C03 (5,3 g/1) to 133,4 ml 
NaHC03 (4,2 g/l). 
Albumin fraction'!.. (Bovine serum) (Boehringer Mannheim, West 
Germany) was prepared as a 5% solution in 0,9% saline . The 
f i bronect i n content was removed us ing aff i n i ty chromatography (see 
under methods below). The fibronectin-free albumin was diluted one in 
ten with 0,9% saline, giving a 5 mg/ml solution, and a further 
dilution of 12 }ll/ml (of this solution) in 0,9% saline was carried 
out to prepare a 60 }lg/ml solution. 
F i bronect i n standards were prepared from rat f i bronect i n 
(Calbiochem-Behring Corporation, La Jolla, California, USA) provided 
at 0,6 mg/ml. A stock solution of 1000 ng/ml was prepared by diluting 
5)11 fibronectin (Fn) to 3 ml with fi ltered sodium carbonate buffer 
(SCB), containing 60 }lg/ml fibronectin-free bovine serum albumin (Fn-
free BSA). A 100 ng/ml stock solution was prepared by a one in ten 
dilution with filtered SCB (containing 60 ).Ig/ml Fn-free BSA), Fn 
standards of 5 ng/ml to 60 ng/ml were freshly prepared in SCB (with 
Fn-free BSA) on the day of use. 
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PBS-Tween. Phosphate buffer (0,2 M, pH 7,0) containing 9 g/1 
NaCl and 1 ml/l Tween 20 (polyoxyethylene sorbitan monolaurate, Merck, 
Schuchardt, West Germany) was prepared by adding 305 ml Na2HP04 (28,39 
gil) and 195 ml NaH2P04·2H20 (31,20 gil) to 500 ml deionised water. 
Goat antiserum to rat fibronectin (Calbiochem-Behring 
Corporation, La Jolla, California, USA) at 1mg/ml was diluted one in 
one thousand with PBS-Tween. 
Rabbit anti-goat lJfu (Sigma, St. Louis, USA) was diluted one in 
one thousand with PBS-Tween. 
Goat anti-rabbit lJfu peroxidase conjugate (Sigma, St. Louis, 
USA) with enzyme activity of 38 purpurogallin units/ml was diluted 
one in one thousand with PBS-Tween. 
Citrate phosphate buffer (0,1 M, pH 4,2) was prepared by adding 
58,6 ml C6H807·H20 (35,85 gil) to 41,6 ml Na2HP04 (28,39 gil). 
2,2'-Azinobis(3-ethylbenzthiazoline sulfonic acid) (ABTS 0,2 mM) 
(Sigma, St. Louis, USA) contained 109,74 mgll ABTS in citrate 
phosphate buffer, pH 4,2 . 
Hydrogen perox i de (H202) (Uni 1 ab, Saarchem, Krugersdorp, South 
Africa) was used at a final concentration of 2 mM. 
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METHODS 
Preparat i on of f i bronect in-free bov i ne serum a 1 bumi n. A 5% 
solution of BSA fraction V in 0,9% saline was passed through a 9,5 cm 
X 0,8 cm (internal diameter) affinity column of gelatin-sepharose 4B 
(Pharmacia Fine Chemicals, Uppsala, Sweden). The Fn-free BSA was 
collected and the Fn was eluted from the column with 10 ml of 2,0 M 
urea. 
Preparation of £ fibronectin standard curve using an ELISA 
(Enzyme Linked Immunosorbent Assay) system (92,93). Plastic 96-well 
flat bottom sterile microtiter plates (with lids) (Dynatech, 
Laboratory and Scientific Equipment Company, Johannesburg, South 
Africa) were used for the ELISA assay. Wells were coated with 100 fl 
of Fn standards (5 ng/ml - 60 ng/ml), with 100 yl of SCB (containing 
60 yg/ml Fn-free BSA) as a blank, or with 100 )11 of Fn-free BSA 
(60 fg/ml), incubated at 370C for 30 minutes and then washed ten times 
with PBS-Tween. 100 fl of diluted (1/1000) goat anti-Fn was added to 
the wells and the plate was incubated at 370C for one hour. Following 
three washes with PBS-Tween, 100 Jll of diluted (1/1000) rabbit anti-
goat 19G was added to the wells and the plate again incubated at 370C 
for 30 minutes . After ten washes with PBS-Tween, 100 fl of diluted 
(1/1000) goat anti-rabbit IgG peroxidase conjugate was added to the 
wells and the plate was incubated for 30 minutes at 370C. Following a 
final wash (ten times with PBS-Tween), 100 fl of substrate (0,2 mM 
ABTS, 2 mM H202 in citrate phosphate buffer, pH 4,2) was added to the 
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we 11 s. The enzyme act i vity was measured after 30 mi nutes i ncubat i on 
at 370C by reading absorbance at 410 nm on a Dynatech Mini-reader II 
(Dynatech Laboratories Inc., Alexandria, Virginia, USA). 
Preparation of cells for determination of fibronectin release. 
LLCMK and BL-5 cells were seeded at 3 X 105 cells per 25 cm2 flask. 
Growth medium was prepared containing 1 pM, 5 pM, 10 ~M and 100 ~M 
vitamin A, as well as a control without ethanol and a control 
containing ethanol (0,1%). The cells were incubated at 370C in 10 ml 
of control or vitamin A-containing medium. The medium was replenished 
on day 4 and was collected in glass vials on day 6. The culture 
medium collected from both LLCMK and BL-5 cells treated with the 
varying concentrations of vitamin A was diluted 1 in 1000 with SCB 
(containing 50 pg/ml Fn-free BSA). The medium was analysed for 
fibronectin content (released by the cells) using the ELISA system 
described above for preparation of a fibronectin standard curve. 
RESULTS 
The fibronectin standard curve over the range of 5 ng/ml to 50 ng/ml 
(0,5 ng/well to 5 ng/well) is shown in figure 17. Each point is the 
mean of six replicate experiments, where each experiment was set up in 
tri p 1 i cate (i e 3 we 11 s), and the absorbance of each we 11 was read 
twice. The standard error of the mean (SEM) bars for the six 
experiments are indicated in figure 17 . 
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FIGURE 17. Fibronectin standard curve. 
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The analyses of t he fibronectin content of LLCMK and BL-6 ce ll media, 
supplemented with varying concentrations of vitamin A, are indicated 
in Table 5. 
TABLE 5. Fibronectin content of LLCMK and BL-6 cell media 
supplemented with different levels of vitamin A. 
----------------------------------------------------------------------
F I BRONECTJ N CON CENTRA TJ ON (H9/ml) 
VIT. Ii O-EtOH O+EtOH l,l!!i 5HM 10,uM 100)!M 
LLCMK 34,1 36,4 50,0 39,4 37,5 45,5 
BL-6 39,8 52,7 49,6 44,3 39,4 48,1 
There appears to be no substantial difference in fibronectin content 
of the LLCMK cell media or the BL-6 cell media at the various levels 
of vitamin A supplementation when compared to the controls. A 
comparison of the fibronectin content of the LLCMK cell media to that 
of the BL-6 cell media again indicates no substantial differences. 
DISCUSSION 
Results from this study indicate that vitamin A supplementation to the 
two cell lines used did not lead to an increased secretion of 
fibronectin into the cell media. This, however, does not rule out the 
possibility that vitamin A supplementation may result in increased 
production of fibronectin in LLCMK and BL-6 cells. Such increased 
production could result in an increase in fibronectin bound to the 
cell surface, as found by Hassell, Pennypacker, Kleinman, Pratt and 
Yamada (88), using in vitro cultured chondrocytes. They proposed that 
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vitamin A appears to regulate cellular accumulation of fibronectin in 
chondrocytes by i ncreas ing the ab i I ity of the ce 11 surf ace to bi nd 
fibronectin. They also proposed that the addition of vitamin A 
resulted in a stimulation of the synthesis or availability of a 
specific receptor for fibronectin . Further investigations would, 
however, have to be undertaken with the cell lines used in this study 
to quantify the fibronectin present on the cell surface before and 
after vitamin A supplementation, before such proposals cou ld be 
substantiated for BL-6 and LLCMK cells. 
Numerous studies have indicated that fibronectin is lost from the cell 
surface of many, but not all, transformed cell lines (77,BO,82,85,87). 
This may be due to a lack of fibronectin synthesis, incomplete 
processing of the glycoprotein molecule or possibly that the 
fibronectin (whether immature or mature) is secreted in to the cell 
media and does not have the ability to bind to the cell surface (80). 
One of the difficulties experienced in assaying fo r fibronectin in 
this study was that the fibronectin standard curve has a sensitivity 
range of 5 ng/ml to 60 ng/ml, which may be too sensitive for the 
quantification of larger amounts of fibronectin, such as those 
measured in this study (ranging from 34 fg/ml to 53 fg/ml). Possibly 
a less sensitive assay system, requiring less dilution of the sample, 
may be more beneficial in quantifying this level of fibronectin. 
In conclusion, different levels of vitamin A supplementation to both 
LLCMK and BL-6 cells did not appear to have a substantial effect on 
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the release of fibronectin into the cell media, and there appeared to 
be no difference in release of fibronectin into the media between the 
untransformed and tumour cell lines. This would suggest that the 
effect of vitamin A supplementation on cell proliferation and cellular 
ultrastructure observed earlier, particularly in the BL-6 cells, did 
not arise through any effect of vitamin A on fibronectin secretion by 
these cells. The possibility that such effects could still arise 
through an effect of vitamin A on fibronectin synthesis and 
fibronectin binding to the cell surface cannot be excluded. This 
would, however, require experimentation to quantify such 
extracellular-bound fibronectin, possibly using some form of urea 
treatment as suggested by Yamada and colleagues (75,83,84). 
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CHAPTER 5 
DISCUSSION AND CONCLUSIONS 
There is a tendency, when developing a hypothesis for a mechanism of 
action of a metabolic substance, to postulate a single mechanism. 
However, when surveying the vast amount of literature available on the 
metabolic and biochemical reactions of vitamin A, several mechanisms 
of action suggest themselves. With respect to the function of vitamin 
A in ce 11 growth and different i at ion, it has been suggested that its 
effect is probably exerted through an association with the cell 
nucleus and mRNA, and/or an effect on the cell surface, possibly 
mediated through an involvement of vitamin A in glycoprotein synthesis 
(1) . 
The effect of vitamin A addition on cell growth in the different cell 
lines used in this study, clearly showed a substantial inhibition of 
tumour cell growth at low non-toxic levels of vitamin A. This effect 
was particularly evident in the BL-6 cell study when using the 
counting plate technique. Here, significant inhibition of cell growth 
on addition of 5 pM and 10 pM vitamin A was observed from day 3. 
Unfortunately, the human hepatoma cell line was lost prior to studies 
on cell growth using the counting plate, and thus the inhibition of 
growth of this cell line on addition of vitamin A could not be 
similarly quantified. The use of the haemocytometer in the study of 
human hepatoma cell growth inhibition resulted in large standard error 
of the mean (SEM) values, hence reducing somewhat the importance of 
the inhibition observed. However, the substantial reduction in cell 
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growth of the human hepatoma ce 11 1 i ne when compared to the opt imum 
growth of this cell line at 1 pM added vitamin A, showed that, indeed, 
the inhibition of growth was substantial, even if not of statistical 
sign if i cance. 
The BL-6 cell growth inhibition study (experiment (a) of Table 3) 
us i ng the haemocytometer showed a higher percentage of growth 
inhibition at the concentrations of 5 pM, 10 pM and 100 pM vitamin A 
supplementation than the duplicate experiment ((b) of Table 3). 
However, these differences in cell growth, when compared to the 
control, although substantial, were not statistically significant, due 
again to the very large SEM values obtained using the haemocytometer. 
The inhibition at 10 pM vitamin A supplementation (60% in experiment 
(a), Table 3) showed a statistical significance of difference at the 
level of p < 0,1 but this was not reported as being statistically 
significant, as the rest of the studies were quantified at the level 
of p < 0,05. By compar i son to the effect on the two tumour ce 11 
lines, addition of vitamin A to the untransformed LLCMK cells elicited 
only a minor effect on cell growth. 
The addition of 100 fM vitamin A, however, had a marked effect on the 
growth of a 11 three ce 11 1 i nes, both tumour and untransformed. Th is 
level of vitamin A supplementation appeared to be cytotoxic to the 
cell lines in this study. This was verified by the transmission 
electron microscopy undertaken to examine the ultrastructural effects 
of the supp 1 emented v itami n A on both the tumour and untransformed 
cells. The large lipid droplets which accumulated in all three cell 
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lines at this high level of vitamin A supplementation were thought to 
disrupt the metabolic functioning of these cells, possibly due to a 
"lipid overload". In mammalian systems, the fat-soluble vitamin A 
tends not to exist in the free state, but is found both 
extracellularly and intracellularly bound to a transport protein (1). 
This protein serves to protect the cells from the destructive effect 
of the fat-soluble vitamin and helps to solubilise the vitamin . . Thus 
in the cells in this study, the intracellular retinol binding protein 
was either not produced, or was produced in amounts far too low to 
cope with the excessive amount of vitamin A administered to the cell 
media. Hence, the destructive effects observed at the high cytotoxic 
level of vitamin A supplementation. 
At the low non-toxic levels of vitamin A supplementation, the tumour 
cells were found to be more susceptible to lipid accumulation than the 
untransformed ce 11 s, an effect wh i ch corre 1 ated we 11 with the ce 11 
growth studies. In control (unsupplemented) cells, both tumour and 
untransformed, small lipid droplets were observed. These droplets may 
contain other fat-soluble components, but may also contain small 
amounts of vitamin A, possibly present in the foetal calf serum in the 
growth medium. These small lipid droplets may playa vital role in 
maintaining normal metabolic functioning of the cells, possibly even 
exerting their effects through the cell nucleus, and then subsequently 
being metabolised. However, a critical level may be reached, where 
the cell can no longer cope if excess lipid, for example vitamin A, 
enters the cell. This may result in accumulation of 1 ipid as 1 ipid 
droplets as was observed in the tumour cells at low non-toxic levels 
of vitamin A supplementation. This may result in an effect on general 
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cell metabol ism and/or on the cell nucleus and thus on transcription 
and translation, leading possibly to an effect on further production 
of retinol binding protein, for example . The cumulative effects may 
thus contribute to cell degeneration, as seen at the cytotoxic levels 
of vitamin A in this study. Obviously a great deal of further 
experimentation is required to substantiate these proposals . 
Kim and Wolf (64) have suggested that at low physiological levels, 
vitamin A may exert an effect on the regulation of synthesis of 
various proteins, such as fibronectin. An increase in v itami n A 
supplementation may thus increase the synthesis of fibronectin or the 
availability of receptors for fibronectin binding on the cell surface 
(as discussed by Hasse 11, Pennypacker, K 1 ei nman, Pratt and Yamada 
(88)), thus resulting in increased adhesiveness of cells and a 
restoration of density dependent growth in tumour cells - in other 
words, a reduction in the number of tumour cells, such as that found 
in this study. 
The vitamin A supplementation, at the non-toxic levels, may also exert 
an extranuclear effect, such as the glycosylation of cell surface 
glycoproteins, for example fibronectin. Many tumour cells are 
characterised by the absence of cell surface fibronectin, which may 
either be due to a lack of synthesis or possibly due to secretion into 
the ce 11 medi a. While this study was inconclusive concerning the 
effects of vitamin A on fibronectin release in cultures of tumour and 
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untransformed cells, the possibility cannot be ruled out that an 
effect may have occurred at the cell surface level, (for example on 
fibronectin receptors), which was not detected by the assay system 
used. 
In conclusion, while vitamin A supplementation to tumour cells in 
particular was found to have a substantial effect on cell growth, no 
mechanism of action of vitamin A on the inhibition of this cell growth 
was unequivocally determined. Various mechanisms were proposed, based 
on the results of this and other studies, but these would require 
further substantiation. However, the suggestion remains that vitamin 
A probably has no single mechanism of action on cell growth, but at 
least two mechanisms, one involving an extranuclear effect and one 
through an effect on the cell nucleus and protein synthesis. 
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SUMMARY 
Vitamin A and its chemical analogues (retinoids) are known to playa 
role in the maintenance and differentiation of epithelial tissue. 
Retinoids have been shown to inhibit carcinogenesis in a number of 
tissues in experimental animals and to inhibit the growth of various 
untransformed and cancer cell lines in vitro. 
This study investigated the effect of retinyl acetate supplemented at 
concentrations of 1 flM, 5 flM, 10 flM and 100 flM to in vitro cultured 
untransformed LLCMK ce 11 s, and transformed BL-6 me 1 anoma and human 
hepatoma cell lines. A small but non-significant effect of vitamin A 
addition on the growth of the untransformed cells was observed, while 
substantial inhibition of proliferation of the two tumour cell lines 
was found . At the cytotoxic level of 100 flM supplemented vitamin A, 
all three cell lines showed marked inhibition of growth . This led to 
an electron microscopy study to examine the ultrastructural effect of 
the vitamin A addition. 
At the low non-toxic levels of vitamin A addition (1 - 10 fM), no 
ultrastructural changes were observed in the untransformed cells. 
However, at a level of 5 fM and 10 flM vitamin A addition in the tumour 
cells, an increase in the size of suspected lipid droplets was 
observed. At the cytotoxic level of 100 flM supplemented vitamin A, 
large lipid droplets were very apparent, as was much cellular 
degeneration. This effect was more marked in the tumour cells than in 
the untransformed cells. The lipid nature of the droplets was 
confirmed by using the lipid stain, Sudan IV. 
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In order to investigate the effect of added vitamin A at the cell 
surface level, an ELISA system was used to quantify the level of the 
cell surface glycoprotein, fibronectin, in the culture media. Vitamin 
A plays an important role in the production of mature fibronectin by 
participating in the glycosylation of the molecule. This study showed 
no major effect of added vitamin A on the release of fibronectin into 
the culture media. This did not, however, exclude the possibility 
that the vitamin A was involved in the production and enhanced binding 
of fibronectin to the cell surface, and was possibly also exerting an 
effect on the availability of fibronectin receptors. Further studies 
would, however, be required to substantiate such effects of vitamin A 
supplementation. 
No single mechanism of action of vitamin A on tumour cell growth 
inhibition was identified, but the possibility that at least two 
mechanisms exist, was suggested. 
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